Trail Ridge Investment Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Trail Ridge Investment Advisors's LLY Position: Q2 2026 in Review
Trail Ridge Investment Advisors reduced its Eli Lilly (LLY) stake by 2.6% in Q2 2026, selling an estimated $36.8K and leaving 1,375 shares worth $1.65M. The position accounts for 0.7% of the portfolio, ranked #36.
Trail Ridge Investment Advisors first reported a position in LLY in Q4 2021 and has held it in 16 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Trail Ridge Investment Advisors held 1,375 shares of Eli Lilly worth $1.65M as of Q2 2026.
- Trail Ridge Investment Advisors sold 36 Eli Lilly shares in Q2 2026, an estimated $36.8K.
- Eli Lilly made up 0.7% of Trail Ridge Investment Advisors's portfolio in Q2 2026, its #36 holding.
- Trail Ridge Investment Advisors first reported a position in Eli Lilly in Q4 2021 and has held it in 16 quarters since.
- 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Trail Ridge Investment Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.